title: Characterization of HIV-specific proliferative T cell responses in HIV-infected persons.
abstract: Virus-specific helper T cell responses are thought to be an important host defense in HIV infection. The proliferative responses to HIV p24, p55, and gp120 were tested in a cohort of 27 HIV-infected subjects. Vigorous proliferative responses directed at the Gag protein with stimulation indices in excess of 6 were detected in 10 of the individuals tested but an Env-specific response was present in only 1 subject. Viral load and proliferative activity to Gag were inversely correlated in untreated individuals. Proliferation was also observed in some individuals treated in the chronic phase of infection, and responses were maintained over time in the absence of detectable viremia. Positive proliferative responses could also occasionally be detected in treated persons with CD4(+) cell counts below 200/microl. Thus, vigorous Gag-specific proliferative responses are present in a minority of HIV-infected individuals and can be detected in individuals receiving highly active antiretroviral therapy at advanced disease stages. Proliferative responses are maintained for an extended time period in the presence of antiviral therapy.
authors.affiliation: Institute for Virology and Immunobiology, University of Würzburg, 97078 Würzburg, Germany.
authors.forename: Y
authors.initials: Y
authors.lastname: Zhang
authors.forename: M
authors.initials: M
authors.lastname: Huber
authors.forename: B
authors.initials: B
authors.lastname: Weissbrich
authors.forename: G
authors.initials: G
authors.lastname: Voss
authors.forename: P
authors.initials: P
authors.lastname: Langmann
authors.forename: H
authors.initials: H
authors.lastname: Klinker
authors.forename: C
authors.initials: C
authors.lastname: Jassoy
mesh_terms: D000328:Adult; D023241:Antiretroviral Therapy, Highly Active; D018791:CD4 Lymphocyte Count; D005260:Female; D016655:HIV Core Protein p24 / Q000276:immunology*; D015699:HIV Envelope Protein gp120 / Q000276:immunology*; D015658:HIV Infections / Q000188:drug therapy / Q000276:immunology*; D006801:Humans; D008213:Lymphocyte Activation; D008297:Male; D008875:Middle Aged; D013601:T-Lymphocytes / Q000502:physiology*; D019562:Viral Load; D014766:Viremia
chemical_list: D016655:HIV Core Protein p24; D015699:HIV Envelope Protein gp120